Market Shaping for Access to Safe, Effective and Affordable Health Commodities [GB-1-202575]

To contribute to better access to essential commodities, improved health outcomes and greater value for money for priority health areas including HIV, TB, malaria, family planning, and vaccines. This is achieved by making health commodity markets work better to bring more low-cost, high-price manufacturers into markets and deliver greater competition, lower prices, faster rollout of new medicines, increased supply security, clearer demand visibility and enhanced incentives for innovation.